ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics

Cancer is a major public health problem around the world and the key leading cause of death in the world. It is well-known that glucolipid metabolism, immunoreaction, and growth/death pattern of cancer cells are markedly different from normal cells. Recently, acyl-CoA synthetase long-chain family 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Jun, Jiang, Changqing, Wen, Xudong, Li, Chengming, Xiong, Shiqiang, Yue, Tian, Long, Pan, Shi, Jianyou, Zhang, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326356/
https://www.ncbi.nlm.nih.gov/pubmed/35910359
http://dx.doi.org/10.3389/fphar.2022.949863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326356/
https://www.ncbi.nlm.nih.gov/pubmed/35910359
http://dx.doi.org/10.3389/fphar.2022.949863

Ejemplares similares